ACOTEC SCIEN.H. DL-00001 (7W3) — Defensive Interval Ratio

Latest as of December 2025: 1202 days

ACOTEC SCIEN.H. DL-00001 (7W3) has a Defensive Interval Ratio of 1202 days as of December 2025. Defensive assets of €768.64 Million (cash €-, short-term investments €548.14 Million, receivables €220.49 Million) cover 1202 days of daily cash needs of €639.30K/day. Check 7W3 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

1202 days
Days of operational coverage

Defensive Assets

€768.64 Million
Cash + ST Investments + Receivables

Daily Cash Need

€639.30K
Current Liabilities ÷ 365

Current Liabilities

€233.34 Million
EUR

ACOTEC SCIEN.H. DL-00001 Defensive Interval Ratio (2021–2025)

This chart shows how ACOTEC SCIEN.H. DL-00001's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 1202 days, meaning defensive assets of €768.64 Million can fund 1202 days of operations without new revenue. Also explore net asset growth rate of ACOTEC SCIEN.H. DL-00001 to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for ACOTEC SCIEN.H. DL-00001 (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for ACOTEC SCIEN.H. DL-00001 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see 7W3 market cap overview.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 1202 days €768.64 Million €639.30K/day €- €548.14 Million ▲ +461 days
2024 742 days €273.90 Million €369.29K/day €- €112.80 Million ▼ -468 days
2023 1210 days €385.22 Million €318.48K/day €- €241.58 Million ▲ +722 days
2022 488 days €131.91 Million €270.34K/day €- €- ▲ +305 days
2021 183 days €44.21 Million €241.40K/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)